Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
About this item
Full title
Author / Creator
Zeuzem, Stefan , Jacobson, Ira M , Baykal, Tolga , Marinho, Rui T , Poordad, Fred , Bourlière, Marc , Sulkowski, Mark S , Wedemeyer, Heiner , Tam, Edward , Desmond, Paul , Jensen, Donald M , Di Bisceglie, Adrian M , Varunok, Peter , Hassanein, Tarek , Xiong, Junyuan , Pilot-Matias, Tami , DaSilva-Tillmann, Barbara , Larsen, Lois , Podsadecki, Thomas and Bernstein, Barry
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this trial in patients with HCV genotype 1 infection and no cirrhosis who had previously been treated with peginterferon and ribavirin, retreatment with three new oral antiviral agents and ribavirin resulted in a sustained virologic response in 96% of patients.
Patients with chronic hepatitis C virus (HCV) infection are at risk for progressiv...
Alternative Titles
Full title
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Authors, Artists and Contributors
Author / Creator
Jacobson, Ira M
Baykal, Tolga
Marinho, Rui T
Poordad, Fred
Bourlière, Marc
Sulkowski, Mark S
Wedemeyer, Heiner
Tam, Edward
Desmond, Paul
Jensen, Donald M
Di Bisceglie, Adrian M
Varunok, Peter
Hassanein, Tarek
Xiong, Junyuan
Pilot-Matias, Tami
DaSilva-Tillmann, Barbara
Larsen, Lois
Podsadecki, Thomas
Bernstein, Barry
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1519258887
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1519258887
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1401561
